Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Modigene CEO Abraham Havron and President Shai Novik will attend.Management will provide a company overview and review of corporatedevelopments.
The presentation will be webcast live and can be accessed by visiting theInvestors section of the Modigene website at www.modigeneinc.com. An archivedversion of the webcast will be available for approximately 90 days. The liveand archived webcast can also be accessed atwww.wsw.com/webcast/rrshq12/modg.ob.
For more information about this conference, visit:www.rodmanandrenshaw.com/conferences?id=6
Modigene Inc. is a biopharmaceutical company applying its patented CTPtechnology to develop longer-acting, proprietary versions of already approvedtherapeutic proteins that currently generate billions of dollars in annualglobal sales. The CTP technology is applicable to virtually all proteins andModigene is currently developing long-acting versions of human growth hormone,interferon beta and erythropoietin, which are in late preclinical development,as well as GLP-1. For more information on Modigene, visitwww.modigeneinc.com.MODIGENE CONTACT: MEDIA CONTACT: Shai Novik, President Barbara Lindheim Modigene Inc. GendeLLindheim BioCom Partners Tel: +1 866 644-7811 +1 212 918-4650 Email: firstname.lastname@example.org
SOURCE Modigene Inc.
You May Also Like